LiteVax BV is a biopharmaceutical company focusing on development and exploitation of innovative vaccine adjuvant concepts. Our mission is to contribute to global health by delivering improved adjuvants for vaccines against infectious and noninfectious diseases. People in developed and developing countries will benefit from better vaccines at lower costs.
Latest newsMore news
Mithra announces topline results for COVID-19 Phase II Study
1 day ago
Biocartis announces restart of its high-throughput cartridge manufacturing line
Thursday September 23rd 2021
Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer
Wednesday September 22nd 2021